The Expert Committee
The Genopole® Expert Committee is made up of independent scientists, businesspeople and other experts who advise Genopole® on the scientific, technical and economic aspects of submitted business plans.
Seventy-eight percent of the business plans presented for incubation since 1998 have been validated by the Expert Committee, which meets three times a year, on average.
Jean DEREGNAUCOURT, Director of Research Applications and Industrial Relations of the Institut Pasteur and Chairman of the Expert Committee since October 16, 2007.
Pierre-Etienne BOST, Member of the French Academy of Technology.
Serge BRAUN, Scientific Director of the French Muscular Dystrophy Association (AFM).
Alain HURIEZ, MD, Chief Executive Officer and Chairman of TcLand-Expression.
Tony MARCEL, President of HealthValue, Vice President of The Medicines Company, France.
Pierre MONSAN, Professor at the University Institute of France, INSA Toulouse (Enzyme Engineering) and the Ecole des Mines, Paris (biotechnology module).
Bernard PAU, Professor of Immunology & Biotechnology. Chairman of the Expert Committee prior to July 10, 2002, Director of the Life Science Department at the CNRS until 2004.
Jean-Pierre RAYNAUD, former Director of Innovation and Technology Forecasting at Roussel-UCLAF. Chairman of Joint Pharma Research, Emeritus Professor at the Pierre & Marie Curie University of Paris VI.
Jean-Loup ROMET-LEMONNE, Managing Partner at BioBusiness.TV, founder and former Chief Executive Officer of ImmunoDesigned Molecules.
Daniel SCHERMAN, Research Director of the joint Unit INSERM 641/CNRS 8151/University Paris-Descartes Unit, Chairman of the Expert Committee from September 2002 to April 2007.
Donny STROSBERG, Professor of Immunology at the University PARIS-VII on secondment, Professor at the Scripps Research Institute.
Daniel THOMAS, Professor of Biotechnology at the University of Technology of Compiegne. Founder and Vice President of the IAR cluster, member of the French Academy of Technology.
Patrick TRICOLI, Global Deputy Head, Collaboration and Innovation, SANOFI-AVENTIS.
Jacques VALLEE, General Partner, SBV Venture Partners.
Etre labellisé Genopole® nous apporte plus de visibilité et de reconnaissance. Safaa Saker, Banque (...)
« Dans les différentes étapes de l’évolution d’Euroas Genomic Bank, les échanges, toujours de grande (...)
« Genopole® a tout simplement permis d’accomplir mon rêve de chercheur : créer un laboratoire capable de (...)